07/2013 - Državni zavod za intelektualno vlasništvo

HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 20, 2013, 7, 2169 – 2293 2225Kazalo podnositelja zahtjeva zaproširenje europskih prijava patenataPodnositelj europske MKP Broj objave europske Naziv izumaprijave patentaprijave patenta(71) (51) (97) (54)AbbVie Inc., US C07D 471/04 (2006.01) EP 2468748 Pyrazoloquinolones are potent parp inhibitorsA61K 31/438 (2006.01)A61P 35/00 (2006.01)C07D 491/04 (2006.01)C07D 495/04 (2006.01)AbbVie Inc., US C07K 16/24 (2006.01) EP 2520588 Dual variable domain immunoglobulin and uses thereofC07K 16/28 (2006.01)C07K 16/46 (2006.01)A61K 39/395 (2006.01)A61P 25/00 (2006.01)AbbVie Inc., US C12N 5/00 (2006.01) EP 2527425 Cell culture improvementsC12N 5/02 (2006.01)C07K 16/00 (2006.01)AbbVie Inc., US C07D 401/14 (2006.01)A61K 31/4545 (2006.01)A61P 3/10 (2006.01)EP 2535338 Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrileC07D 401/04 (2006.01)Amgen Research (Munich) GmbH, DE C07K 16/24 (2006.01) EP 2527370 Compounds having resistance to soluble CEAC07K 16/30 (2006.01)A61K 39/395 (2006.01)Anthrogenesis Corporation, US C12N 5/074 (2010.01) EP 2471904 Placental stem cell populationsAnthrogenesis Corporation, US C12N 5/074 (2010.01) EP 2471905 Placental stem cell populationsAnthrogenesis Corporation, US C12N 5/074 (2010.01) EP 2471906 Placental stem cell populationsAnthrogenesis Corporation, US C12N 5/074 (2010.01) EP 2471907 Placental stem cell populationsArena Pharmaceuticals, Inc., US C07D 231/12 (2006.01)A61K 31/415 (2006.01)A61P 7/00 (2006.01)EP 2527329Crystalline forms and processes for the preparation ofphenyl-pyrazoles useful as modulators of the 5-ht2aserotonin receptorAstraZeneca AB, SE C07D 405/12 (2006.01) EP 2301933 Thiopyrimidine derivative, useful as an intermediate forchemokine receptor modulatorsAstraZeneca AB, SE C07D 405/12 (2006.01) EP 2311827 Thiopyrimidine derivative, useful as an intermediate forchemokine receptor modulators.BARRx Medical, Inc., US A61B 18/18 (2006.01)A61B 19/00 (2006.01)CELGENE CORPORATION, US A61K 31/454 (2006.01)A61K 39/395 (2006.01)C07H 19/20 (2006.01)A61P 35/02 (2006.01)Eisai R&D Management Co., Ltd., JP C07D 307/28 (2006.01)C07D 493/08 (2006.01)C07D 493/18 (2006.01)C07D 307/33 (2006.01)F.Hoffmann-La Roche AG, CH C07D 491/04 (2006.01)C07D 495/04 (2006.01)A61K 31/5377 (2006.01)A61K 31/519 (2006.01)A61P 35/00 (2006.01)EP 2604214EP 2526946EP 2522663EP 2518074Auto-aligning ablating deviceMethods Using 3-(4-Amino-1-Oxo-1,3-Dihydro-Isoindol-2-Yl)-Piperidine-2,6-Dione For Treatment Of CertainLeukemiasIntermediates for the preparation of halichondrin BPhosphoinositide 3-kinase inhibitor compounds andmethods of useGanymed Pharmaceuticals AG, DE C12Q 1/68 (2006.01) EP 2275571 Identification of surface-associated Antigenes used forthe diagnosis and therapy of tumoursGenentech, Inc., US A61K 38/00 (2006.01)C07K 17/00 (2006.01)A61K 39/395 (2006.01)C07K 16/18 (2006.01)A61K 48/00 (2006.01)EP 2500030 Use of complement pathway inhibitors to treat oculardiseasesGenentech, Inc., US C07D 491/04 (2006.01)C07D 495/04 (2006.01)A61K 31/5377 (2006.01)A61K 31/519 (2006.01)A61P 35/00 (2006.01)H. Lundbeck A/S, DK C07D 307/87 (2006.01)A61K 31/343 (2006.01)Ironwood Pharmaceuticals, Inc., US C07D 209/18 (2006.01)C07D 401/12 (2006.01)C07D 401/14 (2006.01)C07D 403/06 (2006.01)C07D 403/14 (2006.01)C07D 417/14 (2006.01)C07D 498/04 (2006.01)A61K 31/404 (2006.01)A61P 29/00 (2006.01)EP 2518074EP 2385044EP 2610244Phosphoinositide 3-kinase inhibitor compounds andmethods of useOrodispersible tablet and process for preparing thesameIndole compoundsISSN 1847-3024